Orbimed Advisors - SYROS PHARMACEUTICALS INC ownership

SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 103 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$5,990,000
-27.1%
1,837,5000.0%0.08%
-14.4%
Q3 2021$8,214,000
-18.0%
1,837,5000.0%0.09%
-10.9%
Q2 2021$10,014,000
-27.1%
1,837,5000.0%0.10%
-21.7%
Q1 2021$13,745,000
-18.9%
1,837,500
+17.6%
0.13%
-12.8%
Q4 2020$16,953,0001,562,5000.15%
Other shareholders

There were no reported owners of SYROS PHARMACEUTICALS INC in Q2 2021.

NameSharesValueWeighting ↓
View complete list of SYROS PHARMACEUTICALS INC shareholders